Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Basaglar in Youth with T1D in Pakistan
NCT06717191Phase 4Completed
- Sponsor
- Diabetes Australia
- Start
- Jun 2022
- Primary completion
- Jun 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of insulin glargine in type 1 diabetes mellitus (T1D), sponsored by Diabetes Australia. Started Jun 2022; status: completed.
02
Drugs
insulin glargine
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT06717191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06717191.